CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
about
New insights into the pathology of podocyte loss: mitotic catastropheAlbumin-induced apoptosis of glomerular parietal epithelial cells is modulated by extracellular signal-regulated kinase 1/2Role of smooth muscle protein SM22α in glomerular epithelial cell injury.Ret is critical for podocyte survival following glomerular injury in vivo.Valproic acid attenuates proteinuria and kidney injury.Interstitial pericytes decrease in aged mouse kidneys.RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signalGlomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosisCdc42 deficiency induces podocyte apoptosis by inhibiting the Nwasp/stress fibers/YAP pathway.Compound effects of aging and experimental FSGS on glomerular epithelial cellsCell cycle control in the kidney.Potential metabolomic biomarkers for evaluation of adriamycin efficacy using a urinary 1H-NMR spectroscopy.Podocyte loss involves MDM2-driven mitotic catastrophe.MDM2 is implicated in high-glucose-induced podocyte mitotic catastrophe via Notch1 signalling.Apoptosis occurs differentially according to glomerular size in diabetic kidney disease.Renal fibrosis: Primacy of the proximal tubule.Angiotensin II-induced podocyte apoptosis is mediated by endoplasmic reticulum stress/PKC-δ/p38 MAPK pathway activation and trough increased Na+/H+ exchanger isoform 1 activity.
P2860
Q26991667-3BECEF7C-BD49-4458-87CD-E072A1194031Q34012450-4FE930EB-F373-41CF-AAD8-FE61FD27D759Q34784037-C4F7DB0F-68A1-452F-9802-D6D1653CEE4EQ35274044-B8A90AFF-596B-410C-B7AB-6B2C86995D2EQ35758297-42D18F35-4A19-4ABC-A91E-8DCEBB2948BAQ35859758-24AACBB1-5BD7-456D-A7F9-7BFC17CABC39Q36070420-39DD6CE5-2604-4A3F-BE0A-4CF0AA3F3C0FQ36303755-D2EBF4FE-48CE-419C-9D85-3DF8BB2EE7CAQ36774995-255031A9-96F8-4AFE-8C35-D6C635939355Q37715505-8A7AE998-399C-4FFC-924C-BBC135FD838DQ38299707-B07752C0-99E7-4B36-8A4C-E291D2DFF756Q39316748-F59FBCF9-5A97-47F9-98E7-810A1188729CQ46048434-17C165FD-26CD-4687-ABF4-26D37BE94334Q47117632-D7F96756-CD05-4A02-9A88-D83699B3898CQ47372589-7C764C05-3811-4287-9A44-6F6CD51B1EEBQ50097164-8C3E6A3B-1F9C-47F6-A202-6C0FE161C62FQ55560616-4A465220-FCCC-4F17-90AB-6AF7AB435753
P2860
CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CDK inhibitor p21 is prosurviv ...... injury, in vitro and in vivo.
@ast
CDK inhibitor p21 is prosurviv ...... injury, in vitro and in vivo.
@en
CDK inhibitor p21 is prosurviv ...... injury, in vitro and in vivo.
@nl
type
label
CDK inhibitor p21 is prosurviv ...... injury, in vitro and in vivo.
@ast
CDK inhibitor p21 is prosurviv ...... injury, in vitro and in vivo.
@en
CDK inhibitor p21 is prosurviv ...... injury, in vitro and in vivo.
@nl
prefLabel
CDK inhibitor p21 is prosurviv ...... injury, in vitro and in vivo.
@ast
CDK inhibitor p21 is prosurviv ...... injury, in vitro and in vivo.
@en
CDK inhibitor p21 is prosurviv ...... injury, in vitro and in vivo.
@nl
P2093
P2860
P1476
CDK inhibitor p21 is prosurviv ...... injury, in vitro and in vivo.
@en
P2093
Caroline B Marshall
Jeffrey W Pippin
Ron D Krofft
Stuart J Shankland
P2860
P304
P356
10.1152/AJPRENAL.00216.2009
P577
2010-02-03T00:00:00Z